Note: Ingredients listed on restricted chemical lists
EC/CAS
231-765-0/7722-84-1
Name of the chemical
Hydrogen peroxide
Concentration
25-40%
General Information
Version
23/02/2023
Revision date
2023-02-23
Product name
Hydrogen peroxide 35 % tech
1.2.1 Relevant identified uses
Industrial purposes, Laboratory use
Icons in SDS
Company Information
company name
Laboratoriumdiscounter
e-mail address of the competent person responsible for the Safety Data Sheet
info@laboratoriumdiscounter.nl
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H332, H314, H335
Hazard statements
Code
Statements
H302+H332
Harmful if swallowed or if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute Tox. 4; H302, Harmful if swallowed. Skin Corr. 1A; H314, Causes severe skin burns and eye damage. Eye Dam. 1; H318, Causes serious eye damage. Acute Tox. 4; H332, Harmful if inhaled. STOT SE 3; H335, May cause respiratory irritation.
Signal word
Danger
Hazard statements
Harmful if swallowed or if inhaled. (H302+H332) Causes severe skin burns and eye damage. (H314) May cause respiratory irritation. (H335)
Precautionary statements
General -
Prevention
Do not breathe vapour/mist. (P260) Wear eye protection/protective gloves/protective clothing. (P280)
Response
IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water . (P303+P361+P353) IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. (P305+P351+P338)
Storage
Store in a well-ventilated place. Keep container tightly closed. (P403+P233)
Disposal
Dispose of contents/container in accordance with local regulation. (P501)
Hazardous Ingredients
hydrogen peroxide solution ...%
Additional information
Not applicable.
2.3 Other hazards
Additional warnings This mixture/product does not contain any substances considered to meet the criteria classifying them as PBT and/or vPvB. This product does not contain any substances considered to be endocrine disruptors in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
